Search Results 21-30 of 18338 for total bilirubin

  1. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Total bilirubin ≤ 1.5 x ULN (except in subjects with Gilbert Syndrome who must have a total bilirubin < 3.0xULN); Giblert syndrome: yes/no; Total ...

  2. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

    ... total serum bilirubin. Clin Biochem. 2019 Jan; 63:148-151 Epub 2018 Oct 03 ... BiliChek transcutaneous bilirubin meter overestimates serum bilirubin as measured ...

  3. NBTXR3 With or Without Cetuximab LA-HNSCC - Mayo Clinic

    Total bilirubin ≤1.5 mg/dL (in participants with Gilbert's syndrome, if ... Total serum magnesium within normal ranges (1.7-2.2 mg/dL or 0.85 to 1.10 ...

  4. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

    Total Bilirubin ≤ 1.5 x ULN. NOTE: For bilirubin elevation 1 to 1.5 x ULN, ALT above 1.5 x ULN (upper limit of normal) is not permitted. · Alanine amino ...

  5. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    ... Total bilirubin =< 1.5 x upper limit of normal (ULN) (or total bilirubin =< 3.0 x ULN with direct bilirubin =< 1.5 x ULN in patients with well-documented ...

  6. The Updated Natural History Model for Primary Biliary Cholangitis - Mayo Clinic

    What is the bilirubin? (mg/dl). What is the albumin? (g/dl). What is the prothrombin time? (seconds). Does the patient have peripheral edema? No; Yes. Is the ...

  7. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

    ... total bilirubin is allowed provided that conjugated bilirubin is ≤ 3.0 x ULN). Estimated Glomerular Filtration Rate (eGFR) ≥ 30 mL/min/1.73 m^2 ...

  8. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    ... total of 35 days after the end of the Double-Blind Treatment Period; ... Serum albumin < 3.5 g/dL; ... Evidence of significant worsening of ALT, AST or bilirubin ...

  9. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Total bilirubin >1.5xULN; Participants with Gilbert's syndrome can be included with total bilirubin <=3.0xULN as long as direct bilirubin is <=1.0xULN.

  10. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients - Mayo Clinic

    Total bilirubin >1.5 × ULN (may be repeated if 1.5–3 × ULN). Total bilirubin >2 × ULN, in case that gilbert's syndrome can be confidently diagnosed, which ...